Suchitra Sundaram

1.8k total citations
25 papers, 148 citations indexed

About

Suchitra Sundaram is a scholar working on Pathology and Forensic Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Suchitra Sundaram has authored 25 papers receiving a total of 148 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pathology and Forensic Medicine, 9 papers in Oncology and 8 papers in Molecular Biology. Recurrent topics in Suchitra Sundaram's work include Lymphoma Diagnosis and Treatment (9 papers), Chronic Lymphocytic Leukemia Research (5 papers) and CAR-T cell therapy research (4 papers). Suchitra Sundaram is often cited by papers focused on Lymphoma Diagnosis and Treatment (9 papers), Chronic Lymphocytic Leukemia Research (5 papers) and CAR-T cell therapy research (4 papers). Suchitra Sundaram collaborates with scholars based in United States, India and Canada. Suchitra Sundaram's co-authors include Pallawi Torka, Francisco J. Hernandez‐Ilizaliturri, Cory Mavis, Cynthia M. Magro, Juan Gu, Usama Gergis, Qunling Zhang, Anil Singh, John K. Erban and G. Thomas Budd and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Suchitra Sundaram

23 papers receiving 143 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Suchitra Sundaram United States 7 54 43 39 23 23 25 148
Bérengère Dadone‐Montaudié France 7 56 1.0× 39 0.9× 14 0.4× 19 0.8× 14 0.6× 23 146
G.M. Mead United Kingdom 7 51 0.9× 26 0.6× 45 1.2× 30 1.3× 34 1.5× 12 186
Dimas Suárez‐Vilela Spain 6 49 0.9× 29 0.7× 41 1.1× 41 1.8× 12 0.5× 8 174
Sigrún Reykdal Iceland 5 27 0.5× 25 0.6× 22 0.6× 27 1.2× 25 1.1× 6 127
Konstantinos Christofyllakis Germany 6 64 1.2× 32 0.7× 45 1.2× 11 0.5× 4 0.2× 30 149
Yoshitaro Torii Japan 8 58 1.1× 21 0.5× 33 0.8× 13 0.6× 20 0.9× 12 186
Dina Sameh Soliman Qatar 8 42 0.8× 42 1.0× 52 1.3× 83 3.6× 13 0.6× 65 208
Maurizio Lalle Italy 9 78 1.4× 40 0.9× 21 0.5× 20 0.9× 9 0.4× 25 269
Aurélie Vogt United States 6 94 1.7× 96 2.2× 20 0.5× 12 0.5× 21 0.9× 12 244
Massimo Granai Italy 8 113 2.1× 38 0.9× 88 2.3× 32 1.4× 14 0.6× 28 184

Countries citing papers authored by Suchitra Sundaram

Since Specialization
Citations

This map shows the geographic impact of Suchitra Sundaram's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Suchitra Sundaram with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Suchitra Sundaram more than expected).

Fields of papers citing papers by Suchitra Sundaram

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Suchitra Sundaram. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Suchitra Sundaram. The network helps show where Suchitra Sundaram may publish in the future.

Co-authorship network of co-authors of Suchitra Sundaram

This figure shows the co-authorship network connecting the top 25 collaborators of Suchitra Sundaram. A scholar is included among the top collaborators of Suchitra Sundaram based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Suchitra Sundaram. Suchitra Sundaram is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mehra, Nikita, Suchitra Sundaram, Parth Shah, & Arunagiri Kuha Deva Magendhra Rao. (2025). Epigenetic Role of Long Non-coding RNAs in Multiple Myeloma. Current Oncology Reports. 27(1). 37–44. 3 indexed citations
2.
Sundaram, Suchitra, et al.. (2025). Abstract 3304: HCAR2 activation limits tumor growth by the activation of p53 signaling in breast cancer. Cancer Research. 85(8_Supplement_1). 3304–3304. 1 indexed citations
3.
Sundaram, Suchitra, Cory Mavis, Juan Gu, et al.. (2024). Targeted BET inhibition with OPN-51107 synergizes with venetoclax in chronic lymphocytic leukemia. Leukemia & lymphoma. 65(14). 2129–2137.
4.
Gu, Juan, Pallawi Torka, Cory Mavis, et al.. (2021). Determinants of COVID-19 Vaccine Response in Patients with Lymphoma on B Cell Directed Therapy. Blood. 138(Supplement 1). 1340–1340. 1 indexed citations
5.
Iyer, Swaminathan P., Auris Huen, Weiyun Z. Ai, et al.. (2021). Safety and Efficacy of Tenalisib Given in Combination with Romidepsin in Patients with Relapsed/Refractory T-Cell Lymphoma: Final Results from a Phase I/II Open Label Multi-Center Study. Blood. 138(Supplement 1). 1365–1365. 12 indexed citations
6.
Akhtar, Othman Salim, Tanya M. Wildes, Suchitra Sundaram, et al.. (2021). Evaluating the role of baseline geriatric assessment in predicting adherence to oral targeted therapies and outcomes in older adults with non-Hodgkin lymphoma.. Journal of Clinical Oncology. 39(15_suppl). 12043–12043. 1 indexed citations
7.
Pandey, Manu, et al.. (2020). Diffuse large B-Cell lymphoma associated with paraneoplastic Guillain–Barré syndrome: A diagnostic and therapeutic challenge. Hematology/Oncology and Stem Cell Therapy. 1 indexed citations
8.
Cao, Shufen, Suchitra Sundaram, Sabarish Ayyappan, et al.. (2020). Aggressive lymphoma subtype is a risk factor for venous thrombosis. Development of lymphoma ‐ specific venous thrombosis prediction models. American Journal of Hematology. 95(8). 918–926. 12 indexed citations
9.
Singh, Anil, Juan Gu, Qunling Zhang, et al.. (2020). Metformin sensitizes therapeutic agents and improves outcome in pre-clinical and clinical diffuse large B-cell lymphoma. SHILAP Revista de lepidopterología. 8(1). 10–10. 25 indexed citations
10.
Olszewski, Adam J., Izidore S. Lossos, Stephen D. Smith, et al.. (2020). Outcomes of Burkitt lymphoma (BL) managed in academic (Acad) or community (Comm) centers: real-world evidence (RWE) from 30 US sites.. Journal of Clinical Oncology. 38(15_suppl). 8043–8043.
11.
Iyer, Swaminathan P., Auris Huen, Bradley M. Haverkos, et al.. (2020). A Multi-Center, Open Label, Phase I/II Study to Assess the Safety and Efficacy of Tenalisib Given in Combination with Romidepsin in Patients with Relapsed/Refractory T-Cell Lymphoma. Blood. 136(Supplement 1). 8–10. 1 indexed citations
12.
Torka, Pallawi, Cory Mavis, Shalin Kothari, et al.. (2020). Pevonedistat, a NEDD8‐activating enzyme inhibitor, induces apoptosis and augments efficacy of chemotherapy and small molecule inhibitors in pre‐clinical models of diffuse large B‐cell lymphoma. SHILAP Revista de lepidopterología. 1(1). 122–132. 12 indexed citations
13.
Gu, Juan, Cory Mavis, Pallawi Torka, Suchitra Sundaram, & Francisco J. Hernandez‐Ilizaliturri. (2020). Potentiate Immune Activation and Function By Targeting Inhibitor of Apoptosis Proteins (IAPs) in Relapse/Refractory DLBCL. Blood. 136(Supplement 1). 30–31. 1 indexed citations
14.
Sundaram, Suchitra, et al.. (2019). Utility of Bone Marrow Biopsy in the Staging of T-Cell Lymphoma in the PET-CT Era. Blood. 134(Supplement_1). 4039–4039. 1 indexed citations
15.
Sundaram, Suchitra, Benjamin Tomlinson, Richard J. Creger, et al.. (2017). Early Cardiovascular Toxicity with Treatment of Follicular Lymphoma Is Associated with Shorter Overall Survival. Blood. 130. 2776–2776. 2 indexed citations
16.
Sundaram, Suchitra, et al.. (2014). Eosinophilic fasciitis as a paraneoplastic syndrome, a case report and review of the literature. Hematology/Oncology and Stem Cell Therapy. 7(2). 90–92. 25 indexed citations
17.
Sundaram, Suchitra, et al.. (2014). Study of Nimotuzumab With Concurrent Chemoradiation Therapy in Patients With Advanced Head-and-Neck Cancer. International Journal of Radiation Oncology*Biology*Physics. 88(2). 493–494. 2 indexed citations
18.
Kannan, A., et al.. (2008). THE ROLE OF ADVERSE LIFESTYLE CHANGES IN THE CAUSATION OF CORONARY ARTERY DISEASE. SHILAP Revista de lepidopterología. 4 indexed citations
19.
Ravdin, Peter M., John K. Erban, Beth Overmoyer, et al.. (2003). 670 Phase III comparison of docetaxel (D)and pacilitaxel (P) in patients with metastatic breast cancer (MBC). European Journal of Cancer Supplements. 1(5). S201–S201. 22 indexed citations
20.
Bashey, Asad, Suchitra Sundaram, Sue Corringham, et al.. (2001). Use of Capecitabine as First-Line Therapy in Patients with Metastatic Breast Cancer Relapsing After High- Dose Chemotherapy and Autologous Stem Cell Support. Clinical Oncology. 13(6). 434–437. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Bérengère Dadone‐Montaudié Breakdown of academic impact, for papers by G.M. Mead Breakdown of academic impact, for papers by Dimas Suárez‐Vilela Breakdown of academic impact, for papers by Sigrún Reykdal Breakdown of academic impact, for papers by Konstantinos Christofyllakis Breakdown of academic impact, for papers by Yoshitaro Torii Breakdown of academic impact, for papers by Dina Sameh Soliman Breakdown of academic impact, for papers by Maurizio Lalle Breakdown of academic impact, for papers by Aurélie Vogt Breakdown of academic impact, for papers by Massimo Granai
Rankless by CCL
2026